AMN Healthcare Services Inc (NYSE:AMN) reported Q2 2017 earnings this Afternoon, coming in at $0.67 per share, beating Wall Street’s estimates of $0.60 per Share. Revenue for the quarter came in at $489.80 million beating analyst estimates of $489.79 million
Analyst Coverage For AMN Healthcare Services Inc (NYSE:AMN)
These are 1 Hold Rating, 4 Buy Ratings .
The current consensus rating for AMN Healthcare Services Inc (NYSE:AMN) is Buy (Score: 2.80) with a consensus target price of $45.80 , a potential (26.87% upside)Recent Insider Trading for AMN Healthcare Services Inc (NYSE:AMN)
- On 6/13/2017 Mark G Foletta, Director, sold 1,500 with an average share price of $36.71 per share and the total transaction amounting to $55,065.00.
- On 3/17/2017 Ralph Henderson, Insider, sold 6,904 with an average share price of $43.00 per share and the total transaction amounting to $296,872.00.
- On 3/2/2017 Andrew M Stern, Director, sold 4,560 with an average share price of $41.63 per share and the total transaction amounting to $189,832.80.
- On 2/28/2017 Paul E Weaver, Director, sold 15,000 with an average share price of $41.37 per share and the total transaction amounting to $620,550.00.
- On 2/23/2017 Ralph Henderson, Insider, sold 3,655 with an average share price of $42.06 per share and the total transaction amounting to $153,729.30.
- On 2/21/2017 Denise L Jackson, General Counsel, sold 10,457 with an average share price of $41.55 per share and the total transaction amounting to $434,488.35.
Recent Trading for AMN Healthcare Services Inc (NYSE:AMN) Shares of AMN Healthcare Services Inc closed the previous trading session at 36.10 up +0.60 1.69% with 646,449 shares trading hands.